Dmitry Balyasny’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Dmitry Balyasny’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,461	Closed	-$325K	–	3384
2022 Q4	$325K	Buy	+26,461	New	+$631K	﹤0.01%	1967

Dmitry Balyasny's CINC Position: Q1 2023 in Review

Dmitry Balyasny sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 26,461 shares — an estimated $325K sold.

Dmitry Balyasny first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $325K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Dmitry Balyasny reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Dmitry Balyasny sold 26,461 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $325K.
Dmitry Balyasny first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Dmitry Balyasny's CinCor Pharma, Inc. Common Stock position peaked at $325K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.